Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren's syndrome: A comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria

Autoimmunity Reviews

Volumn 4, Issue 5, 2005, Pages 276-281

  Locht, Henning ^a   Pelck, Randi ^a   Manthorpe, Rolf ^b  

^a STATENS SERUM INSTITUT   (Denmark)

^b Sjogren's Syndrome Research Centre   (Sweden)

Author keywords

ANA; Anti La; Anti Ro; Autoantibodies; Classification criteria; Sj gren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; LA ANTIBODY; RO ANTIBODY;

CENTROMERE; CLINICAL FEATURE; CLINICAL PRACTICE; COHORT ANALYSIS; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HUMAN; KIDNEY DYSFUNCTION; LABORATORY DIAGNOSIS; LIVER DYSFUNCTION; LUNG DISEASE; LYMPHOCYTIC INFILTRATION; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SJOEGREN SYNDROME; STATISTICAL SIGNIFICANCE;

AUTOANTIBODIES; COHORT STUDIES; DENMARK; DIAGNOSIS, DIFFERENTIAL; EUROPE; HUMANS; PRACTICE GUIDELINES; SJOGREN'S SYNDROME; UNITED STATES;

EID: 21244490734     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2004.12.002     Document Type: Review

References (25)

1. K. Asmussen, V. Andersen, G. Bendixen, K. Bendtzen, J.U. Prause, and J. Thorn Quantitative assessment of clinical disease status in primary Sjogren's syndrome. A cross-sectional study using a new classification model Scand. J. Rheumatol. 26 1997 197 205
2. E. Theander, R. Manthorpe, and L.T. Jacobsson Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study Arthritis Rheum. 50 2004 1262 1269
3. J.P. Hendrick, S.L. Wolin, J. Rinke, M.R. Lerner, and J.A. Steitz Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells Mol. Cell. Biol. 1 1981 1138 1149
4. C.A. O'Brien, K. Margelot, and S.L. Wolin Xenopus Ro ribonucleoproteins: members of an evolutionarily conserved class of cytoplasmic ribonucleoproteins Proc. Natl. Acad. Sci. U. S. A. 90 1993 7250 7254
5. E.M. Tan Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology Adv. Immunol. 44 1989 93 151
6. M. Bachmann, K. Pfeifer, H.C. Schroder, and W.E. Muller The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells Mol. Cell. Biochem. 85 1989 103 114
7. G. Boire, M. Gendron, N. Monast, B. Bastin, and H.A. Menard Purification of antigenically intact Ro ribonucleoproteins: biochemical and immunological evidence that the 52-kD protein is not a Ro protein Clin. Exp. Immunol. 100 1995 489 498
8. C. Boulanger, B. Chabot, H.A. Menard, and G. Boire Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA Clin. Exp. Immunol. 99 1995 29 36
9. G.J. Pruijn, F.H. Simons, and W.J. van Venrooij Intracellular localization and nucleocytoplasmic transport of Ro RNP components Eur. J. Cell Biol. 74 1997 123 132
10. D.P. McCauliffe, and A. Wozniacka 52 kD Ro/SS-A localizes to punctate structures in the cytoplasm of epithelial cells Cell. Mol. Biol. Lett. 8 2003 133 140
11. C. McArthur, Y. Wang, P. Veno, J. Zhang, and R. Fiorella Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha Arch. Oral Biol. 47 2002 443 448
12. C. Vitali, S. Bombardieri, R. Jonsson, H.M. Moutsopoulus, E.L. Alexander, and S.E. Carsons Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Ann. Rheum. Dis. 61 2002 554 558
13. R. Manthorpe, P. Oxholm, J.U. Prause, and M. Schiodt The Copenhagen criteria for Sjogren's syndrome Scand. J. Rheumatol. Suppl. 61 1986 19 21
14. R. Manthorpe Sjogren's syndrome criteria. American-European and Japanese Groups' criteria compared and contrasted Ann. Rheum. Dis. 61 2002 482 484
15. H.M. Markusse, C.H. Veldhoven, A.J. Swaak, and R.T. Smeenk The clinical significance of the detection of anti-Ro/SS-A and anti-La/SS-B autoantibodies using purified recombinant proteins in primary Sjogren's syndrome Rheumatol. Int. 13 1993 147 150
16. A.B. Hassan, I.E. Lundberg, D. Isenberg, and M. Wahren-Herlenius Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus Scand. J. Rheumatol. 31 2002 133 139
17. I.E. Hoffman, I. Peene, L. Meheus, T.W. Huizinga, L. Cebecauer, and D. Isenberg Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus Ann. Rheum. Dis. 63 2004 1155 1158
18. M. Wahren, P. Tengner, I. Gunnarsson, I. Lundberg, E. Hedfors, and N.R. Ringertz Ro/SS-A and La/SS-B antibody level variation in patients with Sjogren's syndrome and systemic lupus erythematosus J. Autoimmun. 11 1998 29 38
19. A. Voss, S. Jacobsen, and N.H. Heegaard Association of beta2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia Lupus 10 2001 533 538
20. J.B. Harley, E.L. Alexander, W.B. Bias, O.F. Fox, T.T. Provost, and M. Reichlin Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome Arthritis Rheum. 29 1986 196 206
21. E.J. Price, and P.J. Venables The etiopathogenesis of Sjogren's syndrome Semin. Arthritis Rheum. 25 1995 117 133
22. A.G. Tzioufas, R. Wassmuth, U.G. Dafni, A. Guialis, H.J. Haga, and D.A. Isenberg Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjogren's syndrome (pSS): a European multicentre study Ann. Rheum. Dis. 61 2002 398 404
23. K. Asmussen, V. Andersen, G. Bendixen, M. Schiodt, and P. Oxholm A new model for classification of disease manifestations in primary Sjogren's syndrome: evaluation in a retrospective long-term study J. Intern. Med. 239 1996 475 482
24. V. Fossaluzza, and S. De Vita Clinical differences between ANA/anti-ENA positive or negative primary Sjogren's syndrome Clin. Rheumatol. 11 1992 385 387
25. B.K. Davidson, C.A. Kelly, and I.D. Griffiths Primary Sjogren's syndrome in the North East of England: a long-term follow-up study Rheumatology (Oxford) 38 1999 245 253